ChemLifeIntel
Access

PREQUEL SKIN

HIGH RISKHQ: — · Private · Founded —
LISTINGPrivateFOUNDED0
FOCUS THERAPY AREAS
Manufacturer
COMPANY INTELLIGENCE SNAPSHOTlive
0
Manufacturing Sites
1
Intelligence Briefs
0
Active Regulatory Actions
HQ Country
NO ACTIVE REGULATORY ACTIONSClean compliance footprint across 0 monitored sites · HQ
View regulatory detail

INTELLIGENCE

Showing 1 of 1 briefs on PREQUEL SKIN
REGULATORY INTELLIGENCE·Recall

PREQUEL SKIN Recalls 30,946 Tubes of Barrier Therapy Cream Due to Microbial Contamination

PREQUEL SKIN has initiated a voluntary Class II recall of 30,946 tubes of BARRIER THERAPY SKIN PROTECTANT CREAM due to microbial contamination. This event, impacting nationwide distribution, underscores critical quality control challenges in non-sterile drug products. Decision-makers must assess supply chain vulnerabilities and reinforce sterility assurance protocols to mitigate similar regulatory and reputational risks.

90-Day Activity
PREQUEL SKINSkin Protectant
PSPriya Subramaniam· Intelligence Analyst
2024-09-18